M. Michele Blackwood, MD, FACS, provided an overview of the significant advancements with personalized medicine with genomic ...

The noninvasive test provides a beneficial screening tool for patients 45 and older at average risk for colorectal cancer.

Robert Jotte, MD, PhD, discusses findings from the phase 3 KRYSTAL-12 study evaluating adagrasib in KRAS G12C-mutated NSCLC.

For Breast Cancer Awareness Month, Oranus Mohammadi, MD, discussed the remarkable progress made in improving survival rates ...